Transcription of Public Assessment Report Repeat-Use Mutual …
{{id}} {{{paragraph}}}
Example: marketing
Public Assessment Report Repeat-Use Mutual …
Public Assessment Report Repeat-Use Mutual recognition Procedure VERSATIS 5% MEDICATED PLASTER lidocaine 5% MEDICATED PLASTER ( lidocaine ) Procedure No: UK/H/1040-1041/001/E03 UK Licence No: PL 21727/0016-0017 Grunenthal Limited MRPAR Versatis/ lidocaine 5% Medicated Plaster UK/H/1040-1041/001/E03 2 LAY SUMMARY VERSATIS 5% MEDICATED PLASTER lidocaine 5% MEDICATED PLASTER ( lidocaine ) This is a summary of the Public Assessment Report (PAR) for Versatis/ lidocaine 5% Medicated Plaster (PL 21727/0016-0017). It explains how Versatis/ lidocaine 5% Medicated Plaster w as assessed and its authorisation recommended, as well as its conditions of use. It is not intended to provide practical advice on how to use Versatis/ lidocaine 5% Medicated Plaster. For practical information about using Versatis/ lidocaine 5% Medicated Plaster, patients should read the package leaflet or contact their doctor or pharmacist. Versatis/ lidocaine 5% Medicated Plaster will be referred to as Versatis/ lidocaine in this Report .
Public Assessment Report . Repeat-Use Mutual Recognition Procedure . VERSATIS 5% MEDICATED PLASTER . LIDOCAINE 5% MEDICATED PLASTER (Lidocaine) Procedure No: UK/H/1040-1041/001/E03
Loading..
Tags:
Information
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document: